UnitedHealth (UNH) Insider Scott Gottlieb Buys 3 Shares
Scott Gottlieb purchased 3 shares of UnitedHealth Group on June 23, 2026.
Reviewed by automated data checks against the source filing. How we make and check alerts
Scott Gottlieb bought 3 shares of UnitedHealth Group Incorporated ($UNH) on June 23, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $UNH is up 1.6% after 1 week, up 3.5% after 1 month and down 1.3% to date (from the $406.75 close on Jun 23, 2026).
UNH
UnitedHealth Group Incorporated
Key Points
- Scott Gottlieb bought 3 shares of UnitedHealth Group (UNH) on June 23, 2026, valued at approximately $1,246.59 based on the stock price of $415.53.
- Other insiders also bought shares on the same day, including Dennis Stankiewicz, who acquired 51 shares, and Patrick Conway, who purchased 83 shares.
- Analysts maintain a positive outlook for UnitedHealth Group, with a consensus buy rating and a mean price target of $477.04.
Get $UNH trade alerts by text
We text you when insiders, Congress or big funds trade $UNH. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated UnitedHealth Group Incorporated alert may contain errors. Disclosures
Gottlieb's Purchase Details
On June 23, 2026, Scott Gottlieb purchased 3 shares of UnitedHealth Group Incorporated (NYSE: UNH) at a price of $415.53 per share. This transaction is valued at approximately $1,246.59. Gottlieb's purchase adds to the ongoing trend of insider buying at the company, which reflects confidence in its future performance.
Insider Buying and Selling at UnitedHealth Group Incorporated
Gottlieb was not the only insider to buy shares on this date. Chief Accounting Officer Dennis Stankiewicz acquired 51 shares, while Patrick Conway, CEO of Optum, bought 83 shares. Other insiders included Kristen Gil with 8 shares, John Noseworthy with 41 shares, and Timothy John Noel with 76 shares. Each of these transactions occurred on June 23, 2026, indicating a strong commitment from multiple executives to the company's prospects.
How UnitedHealth Group Incorporated Stock Has Traded
As of June 23, 2026, UnitedHealth Group shares were trading at $415.53, which is significantly above its 52-week low of $255.97 and close to its 52-week high of $461.62. This performance suggests that the stock has been performing well in the market, and the recent insider purchases may signal further confidence in its trajectory.
Analysts Set New Price Targets
Analysts remain optimistic about UnitedHealth Group's future. On October 16, 2026, JP Morgan maintained an "Overweight" rating with a price target of $524. Earlier, Piper Sandler and Barclays also maintained their "Overweight" ratings, setting targets of $504 and $440, respectively. The consensus among analysts is a buy rating with a mean price target of $477.04, supported by 25 analyst opinions.
What UnitedHealth Group Incorporated Does
UnitedHealth Group is a healthcare company that provides a range of services, including health benefits and pharmacy care, through segments like Optum and UnitedHealthcare. The company serves various markets, including national and public sector employers, making it a key player in the healthcare industry. With a market cap of approximately $365 billion, UnitedHealth continues to be a significant entity in the healthcare space.
What’s Next for UnitedHealth
Investors should keep an eye on UnitedHealth Group's next earnings report scheduled for January 26, 2027. The recent insider transactions are notable as they reflect ongoing confidence from company executives. Remember, the trades reported here may not represent the current positions of the insiders, as these filings reflect past activity.
Related Filing Alerts
Source: Scott Gottlieb's Form 4 filing on $UNH (Jun 23, 2026). Find the original filing: UNH Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts